If your email program has trouble displaying this email, view it as a web page.
 
U.S. Food and Drug Administration Header

FDA Stakeholder Update - Informing FDA stakeholders on key priorities that advance FDA’s public health mission.

November 30, 2018
Dear Colleague,
 
FDA’s 2018 Strategic Policy Roadmap, identified four priority areas that help further our commitment to advance public health and over the past week, FDA has had some notable news and statements that are important to highlight. The four key priority areas are:
  1. Reduce the burden of addiction crises that are threatening American families
  2. Leverage innovation and competition to improve health care, broaden access, and advance public health goals
  3. Empower consumers to make better and more informed decisions about their diets and health; and expand the opportunities to use nutrition to reduce morbidity and mortality from disease
  4. Strengthen FDA’s scientific workforce and its tools for efficient risk management
Key Priority #1: Reduce the burden of addiction crises that are threatening American families
Key Priority #2: Leverage innovation and competition to improve health care, broaden access and advance public health goals
Key Priority #3: Empower consumers to make better and more informed decisions about their diets and health; and expand the opportunities to use nutrition to reduce morbidity and mortality from disease
FDA Voices
  • FDA's Global Efforts to Protect Patients and Consumers from Unsafe Products by: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation and Analysis and Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy - Even in this modern era, when so much can be done remotely, there are many tangible benefits to having “boots on the ground” when doing business overseas. That’s the thinking behind the FDA’s foreign offices, which play a vital role in inspecting foreign manufacturing facilities, gathering market and industry information, and building closer relationships with local regulatory bodies, all in the interests of protecting the public health of Americans (Posted on November 29, 2018).
If you have any questions please feel free to contact our office FDAStakeholderEngagementTeam@fda.hhs.gov.

Our free e-mail alert service allows you to receive important FDA news and information as they become available. Sign up for FDA email updates http://go.fda.gov/subscriptionmanagement and then select the topics that are of interest to you
.



 
 

U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy | www.fda.gov
Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists